Basal cell carcinoma epidemiology and demographics
|
Basal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Basal cell carcinoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Basal cell carcinoma epidemiology and demographics |
|
Basal cell carcinoma epidemiology and demographics in the news |
|
Risk calculators and risk factors for Basal cell carcinoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Saarah T. Alkhairy, M.D.
Overview
The annual incidence of basal cell carcinoma in the United States is approximately 800-1000 cases per 100,000 individuals. The incidence increases with age and is higher among men. BCC is most common in the Caucasian race.
Epidemiology and Demographics
Incidence
Age
- The incidence of BCC increases with age.[2]
- The incidence rate doubles from 40 to 70 years of age.
- The incidence rate for those aged below 40 years is also increasing.
Gender
- Although both are affected, the incidence in males>females.[3]
- This can be explained by gender differences in sun exposure habits and awareness of skin conditions.
- Men are also less likely to seek medical attention, allowing the more advanced development of skin cancer in comparison with women.
Race
- Although it is observed in all races, dark skinned people are less commonly affected than fair skinned ones.
- Whites of celtic ancestry have the highest risk for basal cell cancer.
- Incidence is low in blacks, Asians, and Hispanics
Developed and Developing Countries
- States closer to the equator, such as Hawaii and California, have a higher incidence of BCC compared to midwestern states[4][5]
- An increasing incidence over time has also been noted in other countries, such as Canada, Finland, and Australia[6][7][8]
- Basal cell carcinoma (BCC) is the most common skin cancer among the Far-east Asian race[9]
- Majority of Far-east Asian race are Chinese (44.2%), Malays (32.6%), Bidayuhs (14.0%), and Ibans (6.9%)[9]
References
- ↑ Mohan SV, Chang AL (2014). "Advanced Basal Cell Carcinoma: Epidemiology and Therapeutic Innovations". Curr Dermatol Rep. 3: 40–45. doi:10.1007/s13671-014-0069-y. PMC 3931971. PMID 24587976.
- ↑ Cameron, Michael C.; Lee, Erica; Hibler, Brian P.; Barker, Christopher A.; Mori, Shoko; Cordova, Miguel; Nehal, Kishwer S.; Rossi, Anthony M. (2019). "Basal cell carcinoma". Journal of the American Academy of Dermatology. 80 (2): 303–317. doi:10.1016/j.jaad.2018.03.060. ISSN 0190-9622.
- ↑ Lomas, A.; Leonardi-Bee, J.; Bath-Hextall, F. (2012). "A systematic review of worldwide incidence of nonmelanoma skin cancer". British Journal of Dermatology. 166 (5): 1069–1080. doi:10.1111/j.1365-2133.2012.10830.x. ISSN 0007-0963.
- ↑ Chuang TY, Popescu A, Su WP, Chute CG (1990). "Basal cell carcinoma. A population-based incidence study in Rochester, Minnesota". J Am Acad Dermatol. 22 (3): 413–7. PMID 2312827.
- ↑ Reizner GT, Chuang TY, Elpern DJ, Stone JL, Farmer ER (1993). "Basal cell carcinoma in Kauai, Hawaii: the highest documented incidence in the United States". J Am Acad Dermatol. 29 (2 Pt 1): 184–9. PMID 8335736.
- ↑ Hannuksela-Svahn A, Pukkala E, Karvonen J (1999). "Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995". Arch Dermatol. 135 (7): 781–6. PMID 10411152.
- ↑ Marks R, Staples M, Giles GG (1993). "Trends in non-melanocytic skin cancer treated in Australia: the second national survey". Int J Cancer. 53 (4): 585–90. PMID 8436431.
- ↑ Demers AA, Nugent Z, Mihalcioiu C, Wiseman MC, Kliewer EV (2005). "Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population". J Am Acad Dermatol. 53 (2): 320–8. doi:10.1016/j.jaad.2005.03.043. PMID 16021129.
- ↑ 9.0 9.1 Yap FB (2010). "Clinical characteristics of basal cell carcinoma in a tertiary hospital in Sarawak, Malaysia". Int J Dermatol. 49 (2): 176–9. doi:10.1111/j.1365-4632.2009.04342.x. PMID 20465642.